FDA moves to ban Red Dye No. 3, years after groups petitioned agency
Proposal comes after a 2022 petition cited concerns about the toxicity and carcinogenicity of the dye in animal studies.
The Pharma Letter6 小时
FDA approves Lilly's Omvoh for Crohn's disease
The US Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz), from US pharma major Eli Lilly, for the ...